LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) had Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost of $270.74 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis · last filed 2026-08-07
- 2026-06-30: Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost $270.74M.
- 2026-03-31: Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost $588.75M.
- 2025-12-31: Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost $487.56M.
- 2025-09-30: Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost $477.01M.
| Period end | Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Amortized Cost |
|---|---|
| 2026-06-30 | $270.74M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $588.75M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $487.56M 10-K · filed 2026-02-27 |
| 2025-09-30 | $477.01M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $142.90M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $129.65M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $140.23M 10-K · filed 2025-02-28 |
| 2024-09-30 | $95.72M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $77.01M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $127.97M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $68.84M 10-K · filed 2024-02-29 |
| 2023-09-30 | $78.06M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $95.09M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $134.70M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $59.95M 10-K · filed 2023-02-28 |
| 2022-09-30 | $9.64M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $9.65M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $16.62M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $136.29M 10-K · filed 2022-02-28 |
| 2021-09-30 | $99.42M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $81.28M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $101.40M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $168.59M 10-K · filed 2021-02-24 |
| 2020-09-30 | $143.29M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $488.08M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $474.97M 10-Q · filed 2020-05-08 |